Wright Private Asset Management’s Gilead Sciences GILD Stock Holding History

Wright Private Asset Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q2	$274K	Buy	+5,338	New	+$278K	2.51%	17

Other funds holding GILD

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wright Private Asset Management's GILD Position: Q2 2013 in Review

Wright Private Asset Management opened a new position in Gilead Sciences (GILD) in Q2 2013: 5,338 shares worth $274K. The stake represents 2.51% of the portfolio and ranks #17 among its holdings.

948 funds tracked by Wall St. Rank hold GILD as of Q2 2013.

Wright Private Asset Management held 5,338 shares of Gilead Sciences worth $274K as of Q2 2013.
Gilead Sciences was a new Wright Private Asset Management position in Q2 2013.
Gilead Sciences made up 2.51% of Wright Private Asset Management's portfolio in Q2 2013, its #17 holding.
948 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2013.

Based on Wright Private Asset Management's 13F filing for Q2 2013, filed 31 Jul 2013.